Smart Cap ‘Timesulin’ Offers Major Advance in Diabetes Compliance
Innovative solution shows insulin-dependent patients how long it’s been since their last injection to help improve quality of life with diabetes
London, February 2013: Timesulin, an innovative replacement cap for insulin pens from Patients Pending Ltd., seamlessly transforms all major insulin pens into a smart pen to show how long it’s been since the last insulin injection, helping users avoid accidental double or missed insulin doses. This innovative solution represents a major step forward for people using insulin to treat their diabetes - of whom up to a third inadvertently skip doses or otherwise fail to take their diabetes medication as prescribed. Timesulin offers the first real improvement for traditional insulin pens since their release more than 25 years ago.
With the International Diabetes Federation now estimating the global number of people living with diabetes at 366 million - twice as many as 30 years ago - the market for innovation in diabetes management is wide open, and not many manage to succeed in this competitive field.
This is why Timesulin has already generated excitement amongst established names in the diabetes field in Europe, including Dr Åke Sjöholm, Chief of the Diabetes Research Unit at Stockholm’s Karolinska Institutet in Sweden. "Due to the habitual nature of insulin administration patients often forget whether or not they had injected their insulin dose," Dr Sjöholm notes. "We regard this as a major challenge in managing diabetes and welcome the timely arrival of an innovative solution like Timesulin."
The smart cap, which seamlessly Continue reading